Steroids Decrease Prevalence of Positive Tuberculin Skin Test in Rheumatoid Arthritis: Implications on Anti-TNF Therapies
Open Access
- 1 January 2014
- journal article
- research article
- Published by Wiley in Interdisciplinary Perspectives on Infectious Diseases
- Vol. 2014, 1-5
Abstract
Tuberculin skin test has been used as an indicator of latent tuberculosis in patients with Rheumatoid Arthritis (RA) before administration of biologicals. Effect of Disease modifying antirheumatic drugs (DMARDs) and steroids on the result of tuberculin skin test (TST) may have important implications in interpretation of results of this test.Objectives. To find the prevalence of positive TST in rheumatoid patients and the effect of standard treatment on the results of TST.Method. In this cross-sectional study two hundred and fifty patients of RA above 18 years of age, classified using 1987 ACR criteria for RA, were enrolled from rheumatology outdoor. Demographics, disease activity, disease duration, and therapy were recorded. All patients underwent TST.Results. Fifty-one (20.4%) patients were found to be tuberculin positive. Tuberculin positivity was not affected by MTX intake but it was significantly low in patients with recent steroid intake as compared to patients who had not taken steroids in last 3 months (3% versus 25%,P= 0.002).Conclusion. Prevalence of tuberculin positivity in patients with RA was found to be low. Results were not affected by methotrexate; however tuberculin skin test results in patients with recent use of steroids are likely to be negative.Keywords
Funding Information
- Council of Scientific and Industrial Research (13(8478-A)/Pool-2011)
This publication has 29 references indexed in Scilit:
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)Annals of the Rheumatic Diseases, 2010
- Risk Factors for Positive Tuberculin Skin Test in Guinea-BissauEpidemiology, 2007
- Increased risk of tuberculosis in patients with rheumatoid arthritis in JapanAnnals of the Rheumatic Diseases, 2006
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006Annals of the Rheumatic Diseases, 2006
- Recomendações para diagnóstico e tratamento da tuberculose latente e activa nas doenças inflamatórias articulares candidatas a tratamento com fármacos inibidores do factor de necrose tumoral alfaRevista Portuguesa de Pneumologia (English Edition), 2006
- Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in SwedenArthritis & Rheumatism, 2005
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- RHEUMATOID ARTHRITIS AND ITS TREATMENT BY GOLD SALTS*1The Lancet, 1934
- TREATMENT OF ARTHRITIS AND RHEUMATISM WITH GOLDThe Lancet, 1934